Parapro Llc patents expiration
1. Natroba patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6063771 | PARAPRO LLC | Formulations for controlling human lice |
Jul, 2023
(2 months ago) | |
| US9895388 | PARAPRO LLC | Methods and compositions useful for controlling cutaneous mites |
Nov, 2033
(10 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication (I) | Apr 28, 2024 |
Drugs and Companies using SPINOSAD ingredient
Market Authorisation Date: 18 January, 2011
Treatment: Natroba topical suspension is a pediculicide indicated for the topical treatment of head lice infestation in patients six (6) months of age and older.; The product composition (natroba) is for the top...
Dosage: SUSPENSION;TOPICAL
More Information on Dosage
NATROBA family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic